Literature DB >> 9404702

Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.

W M Schoell1, D Pieber, O Reich, M Lahousen, M Janicek, F Guecer, R Winter.   

Abstract

BACKGROUND: The growth of a malignant tumor requires the formation of new capillaries. Quantification of these microvessels is difficult. The purpose of this study was to establish an objective technique for quantifying angiogenesis and to evaluate whether microvessel quantity may predict tumor aggressiveness in patients with ovarian carcinoma.
METHODS: Endothelial area was used to quantify microvessel density in immunohistochemically stained sections of 28 International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinomas. The endothelial area was measured with a computer-aided image analysis system in the subepithelial stroma of highest vascularization. The endothelial area in the specimens of 14 patients who survived for > or =6 years was compared with that of 14 patients matched for stage and treatment who died of the disease.
RESULTS: The mean tumor area analyzed was 5.04 +/- 0.23 mm2. The mean endothelial area per mm2 of stroma from survivors and dead patients was 0.038 +/- 0.026 mm2 and 0.110 +/- 0.034 mm2, respectively (P < 0.0001). No significant differences were found in histology, tumor grade, status of lymph nodes, and amount of residual tumor.
CONCLUSIONS: Image analysis was used to overcome the potential subjectivity of manual counts. Computer-assisted image analysis can evaluate accurately the angiogenic potential in ovarian carcinomas. Tumor angiogenesis may prove to be a prognostic factor in patients with ovarian carcinoma. This study suggests that the measurement of the endothelial area would be clinically useful in determining microvessel density [See editorial on pages 2219-21, this issue.]

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404702

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  Angiogenesis in epithelian ovarian cancer.

Authors:  E S Bamberger; C W Perrett
Journal:  Mol Pathol       Date:  2002-12

Review 3.  Vascular endothelial growth factor in ovarian cancer.

Authors:  D A Hazelton; T C Hamilton
Journal:  Curr Oncol Rep       Date:  1999-09       Impact factor: 5.075

Review 4.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

5.  Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines.

Authors:  M Pia Morelli; Amy M Brown; Todd M Pitts; John J Tentler; Fortunato Ciardiello; Anderson Ryan; Juliane M Jürgensmeier; S Gail Eckhardt
Journal:  Mol Cancer Ther       Date:  2009-09-15       Impact factor: 6.261

6.  Does Aquaporin-1 expression have clinical significance in serous epithelial ovarian cancer?

Authors:  Mustafa Kemal Takal; Cem Baykal; Eralp Başer; Mustafa Derda Kaya; Polat Dursun; Ozlem Ozen; Asuman Nihan Haberal; Ali Ayhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-09-01

7.  Digital microscopy assessment of angiogenesis in different breast cancer compartments.

Authors:  Anca Haisan; Radu Rogojanu; Camelia Croitoru; Daniela Jitaru; Cristina Tarniceriu; Mihai Danciu; Eugen Carasevici
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

8.  Computer-aided Image Processing of Angiogenic Histological.

Authors:  Matvey Sprindzuk; Alexander Dmitruk; Vassili Kovalev; Armen Bogush; Alexander Tuzikov; Victor Liakhovski; Mikhail Fridman
Journal:  J Clin Med Res       Date:  2009-12-28

9.  The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.

Authors:  Nicole A Hofmann; Jiang Yang; Sunia A Trauger; Hironao Nakayama; Lan Huang; Dirk Strunk; Marsha A Moses; Michael Klagsbrun; Joyce Bischoff; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

10.  Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.

Authors:  Pierre Kunz; Jörg Fellenberg; Linda Moskovszky; Zoltan Sápi; Tibor Krenacs; Johannes Poeschl; Burkhard Lehner; Miklos Szendrõi; Volker Ewerbeck; Ralf Kinscherf; Benedikt Fritzsching
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.